Advertisement

Acute and Chronic Paronychia

  • Adam I. Rubin
  • C. Ralph DanielIII
Chapter
First Online:

Abstract

Paronychia refers to the inflammation and/or infection of the nail folds. It occurs in to forms commonly: acute paronychia and chronic paronychia. Both forms are caused by a disruption of the normal seals of the nail apparatus. The disruption of the seals in the nail apparatus is commonly caused by irritants, contactants, as wells as repetitive trauma from manicures. Acute paronychia often demonstrates a distinct collection of pus or abscess formation within a nail fold. The most common cause of acute paronychia is Staphylococcus aureus. It may also be caused by other organisms including methicillin resistant Staphylococcus aureus. Chronic paronychia refers to paronychia that lasts more than 6 weeks. The treatments for acute and chronic paronychia are distinct. Chronic paronychia is considered to be an inflammatory process, although there can be secondary colonization by Candida and hypersensitivity to Candida may play a role in persistence and exacerbation of the process.

Keywords

Paronychia Acute paronychia Chronic paronychia Finger sucking Nail biting Onychophagia Onychotillomania Staphylococcus aureus Methicillin resistant Staphylococcus aureus MRSA Hangnail Candida Incision and drainage Nail soaks Soaks Eponychial marsupialization Marsupialization En block removal of nail fold Swiss roll technique 
This is a preview of subscription content, log in to check access.

Supplementary material

324020_4_En_13_MOESM1_ESM.pdf (34 kb)
Patient Handout (PDF 34 kb)

References

  1. 1.
    Daniel CR 3rd, Tosti A, Iorizzo M, Piraccini BM. The nail and Koebner-like phenomenon. Int J Dermatol. 2006;45(11):1372–3.  https://doi.org/10.1111/j.1365-4632.2006.02958.x.CrossRefPubMedGoogle Scholar
  2. 2.
    Daniel CR 3rd, Daniel MP, Daniel J, Sullivan S, Bell FE. Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen. Cutis. 2004;73(1):81–5.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Shemer A, Daniel CR 3rd. Common nail disorders. Clin Dermatol. 2013;31(5):578–86.  https://doi.org/10.1016/j.clindermatol.2013.06.015.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bahunuthula RK, Thappa DM, Kumari R, Singh R, Munisamy M, Parija SC. Evaluation of role of Candida in patients with chronic paronychia. Indian J Dermatol Venereol Leprol. 2015;81(5):485–90.  https://doi.org/10.4103/0378-6323.158635.CrossRefPubMedGoogle Scholar
  5. 5.
    Tosti A, Guerra L, Morelli R, Bardazzi F, Fanti PA. Role of foods in the pathogenesis of chronic paronychia. J Am Acad Dermatol. 1992;27(5 Pt 1):706–10.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gorva AD, Mohil R, Srinivasan MS. Aggressive digital papillary adenocarcinoma presenting as a paronychia of the finger. J Hand Surg. 2005;30(5):534.  https://doi.org/10.1016/j.jhsb.2005.01.011.CrossRefGoogle Scholar
  7. 7.
    Kuschner SH, Lane CS. Squamous cell carcinoma of the perionychium. Bulletin. 1997;56(2):111–2.Google Scholar
  8. 8.
    Ko JH, Young A, Wang KH. Paronychia-like digital cutaneous metastasis. Br J Dermatol. 2014;171(3):663–5.  https://doi.org/10.1111/bjd.13025.CrossRefPubMedGoogle Scholar
  9. 9.
    Giacomel J, Lallas A, Zalaudek I, Argenziano G. Periungual Bowen disease mimicking chronic paronychia and diagnosed by dermoscopy. J Am Acad Dermatol. 2014;71(3):e65–7.  https://doi.org/10.1016/j.jaad.2014.01.894.CrossRefPubMedGoogle Scholar
  10. 10.
    Fung V, Sainsbury DC, Seukeran DC, Allison KP. Squamous cell carcinoma of the finger masquerading as paronychia. J Plast Reconstr Aesthet Surg JPRAS. 2010;63(2):e191–2.  https://doi.org/10.1016/j.bjps.2009.02.091.CrossRefPubMedGoogle Scholar
  11. 11.
    Lovett JE, Haines TA, Bentz ML, Shestak KC, Flynn KJ, Kapadia SB. Subungual keratoacanthoma masquerading as a chronic paronychia. Ann Plast Surg. 1995;34(1):84–7.CrossRefPubMedGoogle Scholar
  12. 12.
    High DA, Luscombe HA, Kauh YC. Leukemia cutis masquerading as chronic paronychia. Int J Dermatol. 1985;24(9):595–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Betti R, Vergani R, Inselvini E, Tolomio E, Crosti C. Guess what! Subungual squamous cell carcinoma mimicking chronic paronychia. Eur J Dermatol EJD. 2000;10(2):149–50.PubMedGoogle Scholar
  14. 14.
    Shepherd DM, Dzikowski CM, Chussid F. Bronchogenic carcinoma mimicking paronychia and osteomyelitis in the great toe. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg. 1997;36(2):115–9.Google Scholar
  15. 15.
    Cohen PR, Buzdar AU. Metastatic breast carcinoma mimicking an acute paronychia of the great toe: case report and review of subungual metastases. Am J Clin Oncol. 1993;16(1):86–91.CrossRefPubMedGoogle Scholar
  16. 16.
    Rockwell PG. Acute and chronic paronychia. Am Fam Physician. 2001;63(6):1113–6.PubMedGoogle Scholar
  17. 17.
    Ritting AW, O’Malley MP, Rodner CM. Acute paronychia. J Hand Surg. 2012;37(5):1068–70; quiz page 70.  https://doi.org/10.1016/j.jhsa.2011.11.021.CrossRefPubMedGoogle Scholar
  18. 18.
    Whitehead SM, Eykyn SJ, Phillips I. Anaerobic paronychia. Br J Surg. 1981;68(6):420–2.CrossRefPubMedGoogle Scholar
  19. 19.
    Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg. 2014;22(3):165–74.  https://doi.org/10.5435/JAAOS-22-03-165.CrossRefPubMedGoogle Scholar
  20. 20.
    Jebson PJ. Infections of the fingertip. Paronychias and felons. Hand Clin. 1998;14(4):547–55. viii.PubMedGoogle Scholar
  21. 21.
    Daniel CR 3rd. Paronychia. Dermatol Clin. 1985;3(3):461–4.CrossRefPubMedGoogle Scholar
  22. 22.
    Brook I. Aerobic and anaerobic microbiology of paronychia. Ann Emerg Med. 1990;19(9):994–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Brook I. Paronychia: a mixed infection. Microbiology and management. J Hand Surg. 1993;18(3):358–9.CrossRefGoogle Scholar
  24. 24.
    Tosti R, Samuelsen BT, Bender S, Fowler JR, Gaughan J, Schaffer AA, et al. Emerging multidrug resistance of methicillin-resistant Staphylococcus aureus in hand infections. J Bone Joint Surg Am. 2014;96(18):1535–40.  https://doi.org/10.2106/JBJS.M.01159.CrossRefPubMedGoogle Scholar
  25. 25.
    Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician. 2008;77(3):339–46.PubMedGoogle Scholar
  26. 26.
    Tosti R, Ilyas AM. Empiric antibiotics for acute infections of the hand. J Hand Surg. 2010;35(1):125–8.  https://doi.org/10.1016/j.jhsa.2009.10.024.CrossRefGoogle Scholar
  27. 27.
    Kirkland EB, Adams BB. Methicillin-resistant Staphylococcus aureus and athletes. J Am Acad Dermatol. 2008;59(3):494–502.  https://doi.org/10.1016/j.jaad.2008.04.016.CrossRefPubMedGoogle Scholar
  28. 28.
    Elston DM. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: management principles and selection of antibiotic therapy. Dermatol Clin. 2007;25(2):157–64, vi.  https://doi.org/10.1016/j.det.2007.01.007.CrossRefPubMedGoogle Scholar
  29. 29.
    Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56(1):1–16; quiz 7–20.  https://doi.org/10.1016/j.jaad.2006.04.018.CrossRefPubMedGoogle Scholar
  30. 30.
    Wollina U. Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid. J Eur Acad Dermatol Venereol JEADV. 2001;15(1):82–4.CrossRefPubMedGoogle Scholar
  31. 31.
    Daniel CR 3rd, Daniel MP, Daniel CM, Sullivan S, Ellis G. Chronic paronychia and onycholysis: a thirteen-year experience. Cutis. 1996;58(6):397–401.PubMedGoogle Scholar
  32. 32.
    Baran R. Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects. Clin Exp Dermatol. 1986;11(2):148–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Blumental G. Paronychia and pyogenic granuloma-like lesions with isotretinoin. J Am Acad Dermatol. 1984;10(4):677–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Zerboni R, Angius AG, Cusini M, Tarantini G, Carminati G. Lamivudine-induced paronychia. Lancet. 1998;351(9111):1256.  https://doi.org/10.1016/S0140-6736(05)79324-7.CrossRefPubMedGoogle Scholar
  35. 35.
    Colson AE, Sax PE, Keller MJ, Turk BK, Pettus PT, Platt R, et al. Paronychia in association with indinavir treatment. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(1):140–3.  https://doi.org/10.1086/317546.CrossRefGoogle Scholar
  36. 36.
    Chanprapaph K, Vachiramon V, Rattanakaemakorn P. Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management. Dermatol Res Pract. 2014;2014:734249.  https://doi.org/10.1155/2014/734249.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Giusti RM, Shastri KA, Cohen MH, Keegan P, Pazdur R. FDA drug approval summary: panitumumab (Vectibix). Oncologist. 2007;12(5):577–83.  https://doi.org/10.1634/theoncologist.12-5-577.CrossRefPubMedGoogle Scholar
  38. 38.
    Seiden MV, Burris HA, Matulonis U, Hall JB, Armstrong DK, Speyer J, et al. A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum- resistant ovarian and primary peritoneal malignancies. Gynecol Oncol. 2007;104(3):727–31.  https://doi.org/10.1016/j.ygyno.2006.10.019.CrossRefPubMedGoogle Scholar
  39. 39.
    Nakano J, Nakamura M. Paronychia induced by gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Dermatol. 2003;30(3):261–2.CrossRefPubMedGoogle Scholar
  40. 40.
    Kiyohara Y, Yamazaki N, Kishi A. Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol. 2013;69(3):463–72.  https://doi.org/10.1016/j.jaad.2013.02.025.CrossRefPubMedGoogle Scholar
  41. 41.
    Rigopoulos D, Gregoriou S, Belyayeva Y, Larios G, Gkouvi A, Katsambas A. Acute paronychia caused by lapatinib therapy. Clin Exp Dermatol. 2009;34(1):94–5.  https://doi.org/10.1111/j.1365-2230.2008.02928.x.CrossRefPubMedGoogle Scholar
  42. 42.
    Lacouture ME, Schadendorf D, Chu CY, Uttenreuther-Fischer M, Stammberger U, O’Brien D, et al. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Expert Rev Anticancer Ther. 2013;13(6):721–8.  https://doi.org/10.1586/era.13.30.CrossRefPubMedGoogle Scholar
  43. 43.
    Robert C, Sibaud V, Mateus C, Verschoore M, Charles C, Lanoy E, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):e181–9.  https://doi.org/10.1016/S1470-2045(14)71133-7.CrossRefPubMedGoogle Scholar
  44. 44.
    Daniel CR 3rd, Iorizzo M, Piraccini BM, Tosti A. Grading simple chronic paronychia and onycholysis. Int J Dermatol. 2006;45(12):1447–8.  https://doi.org/10.1111/j.1365-4632.2006.03128.x.CrossRefPubMedGoogle Scholar
  45. 45.
    Daniel CR 3rd, Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol. 1998;37(12):904–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Canales FL, Newmeyer WL 3rd, Kilgore ES Jr. The treatment of felons and paronychias. Hand Clin. 1989;5(4):515–23.PubMedGoogle Scholar
  47. 47.
    Kapellen TM, Galler A, Kiess W. Higher frequency of paronychia (nail bed infections) in pediatric and adolescent patients with type 1 diabetes mellitus than in non-diabetic peers. J Pediatr Endocrinol Metab JPEM. 2003;16(5):751–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Stone OJ, Mullins JF. Chronic paronychia: microbiology and histopathology. Arch Dermatol. 1962;86:324–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73–6.CrossRefPubMedGoogle Scholar
  50. 50.
    Biesbroeck LK, Fleckman P. Nail disease for the primary care provider. Med Clin North Am. 2015;99(6):1213–26.  https://doi.org/10.1016/j.mcna.2015.07.010.CrossRefPubMedGoogle Scholar
  51. 51.
    Baran R. Common-sense advice for the treatment of selected nail disorders. J Eur Acad Dermatol Venereol JEADV. 2001;15(2):97–102.CrossRefPubMedGoogle Scholar
  52. 52.
    Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol. 2009;160(4):858–60.  https://doi.org/10.1111/j.1365-2133.2008.08988.x.CrossRefPubMedGoogle Scholar
  53. 53.
    Keyser JJ, Eaton RG. Surgical cure of chronic paronychia by eponychial marsupialization. Plast Reconstr Surg. 1976;58(1):66–70.CrossRefPubMedGoogle Scholar
  54. 54.
    Bednar MS, Lane LB. Eponychial marsupialization and nail removal for surgical treatment of chronic paronychia. J Hand Surg. 1991;16(2):314–7.CrossRefGoogle Scholar
  55. 55.
    Baran R, Bureau H. Surgical treatment of recalcitrant chronic paronychias of the fingers. J Dermatol Surg Oncol. 1981;7(2):106–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatol Surg Off Publ Am Soc Dermatol Surg [et al.]. 2006;32(3):393–8; discussion 8–9.  https://doi.org/10.1111/j.1524-4725.2006.32079.x.PubMedGoogle Scholar
  57. 57.
    Pabari A, Iyer S, Khoo CT. Swiss roll technique for treatment of paronychia. Tech Hand Up Extrem Surg. 2011;15(2):75–7.  https://doi.org/10.1097/BTH.0b013e3181ec089e.CrossRefPubMedGoogle Scholar
  58. 58.
    Stone OJ, Mullins JF. Chronic paronychia in children. Clin Pediatr. 1968;7(2):104–7.CrossRefGoogle Scholar
  59. 59.
    Durdu M, Ruocco V. Clinical and cytologic features of antibiotic-resistant acute paronychia. J Am Acad Dermatol. 2014;70(1):120–6 e1.  https://doi.org/10.1016/j.jaad.2013.09.042.CrossRefPubMedGoogle Scholar
  60. 60.
    Rayan GM, Turner WT. Hand complications in children from digital sucking. J Hand Surg. 1989;14(6):933–6.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of DermatologyHospital of the University of Pennsylvania, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of DermatologyUniversity of Mississippi Medical Center, Dermatology & Surgery of the SkinJacksonUSA

Personalised recommendations

Cite chapter

Buy options